Description

Vapreotide is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)–Neuroscience-Neuromodulation–C57H70N12O9S2—-[1]Spitsin S et al. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. Neuroimmunomodulation. 2013;20(5):247-55.–103222-11-3–1131.37–98.06–O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC1=O)CCCCN)=O)C(C)C)=O)C(N[C@H](C(N)=O)CC2=CNC3=CC=CC=C23)=O)NC([C@H](N)CC4=CC=CC=C4)=O)=O)CC5=CC=C(C=C5)O)N[C@@H]1CC6=CNC7=CC=CC=C67–Cancer–H2O : 100 mg/mL (ultrasonic)–Neurokinin Receptor–NK1–GPCR/G Protein;Neuronal Signaling–Peptides